Cefepime Treatment for Campylobacter Infections

Introduction to Cefepime Limitations

• The World Health Organization recommends macrolides, such as azithromycin or erythromycin, as the first-line treatment for Campylobacter gastroenteritis, based on established clinical practice and microbiological susceptibility patterns 1
• The Infectious Diseases Society of America suggests fluoroquinolones, such as ciprofloxacin or levofloxacin, as alternative agents for Campylobacter infections, though resistance rates are increasing in many geographic regions 1

Clinical Guidelines for Cefepime Use

• The American College of Emergency Physicians advises against using cefepime monotherapy for suspected or confirmed Campylobacter infections, as this represents inappropriate antimicrobial selection that will likely result in treatment failure 1
• The Society for Healthcare Epidemiology of America recommends that cefepime is designed for nosocomial gram-negative infections, febrile neutropenia, and complicated urinary tract infections—not gastrointestinal pathogens 2